Zai Lab (ZLAB) Cash from Investing Activities (2018 - 2026)

Zai Lab (ZLAB) posted quarterly Cash from Investing Activities of -$22.3 million for Q1 2026, down 106.83% year-on-year from $326.1 million in Q1 2025, and down 97.31% on a QoQ basis from -$11.3 million in Q4 2025.

Zai Lab (ZLAB) Cash from Investing Activities (2018 - 2026) Analysis & Trends

Zai Lab (ZLAB) has reported Cash from Investing Activities for 9 consecutive years, with -$22.3 million the latest figure, recorded in Q1 2026.

  • Quarterly Cash from Investing Activities fell 106.83% year-over-year to -$22.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$40.6 million (up 22.53% YoY) and the FY2025 annual result came in at $307.9 million, up 182.06% from the prior year.
  • Cash from Investing Activities slipped to -$22.3 million in Q1 2026 per ZLAB's latest filing, from -$11.3 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for ZLAB reached as high as $568.3 million in Q3 2022 and fell as low as -$347.8 million in Q4 2024.
  • A 5-year average of $18.8 million and a median of -$4.4 million in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities sank 2622.65% — and 2025, when it soared 9806.83%.
  • Year by year, Cash from Investing Activities stood at -$4.4 million in 2022, then jumped by 430.6% to $14.5 million in 2023, then sank by 2505.44% to -$347.8 million in 2024, then jumped by 96.75% to -$11.3 million in 2025, then slumped by 97.31% to -$22.3 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$22.3 million, -$11.3 million, and -$4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 172.62 Mn
10 Zai Lab 20.66 Bn 19.91 Bn 61.30 Mn -22.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -22.29 Mn
Mar 31, 2026 -22.29 Mn
Dec 31, 2025 -11.30 Mn
Dec 31, 2025 -11.30 Mn
Sep 30, 2025 -4.05 Mn
Sep 30, 2025 -4.05 Mn
Jun 30, 2025 -2.92 Mn
Jun 30, 2025 -2.92 Mn
Mar 31, 2025 326.13 Mn
Mar 31, 2025 326.13 Mn
Dec 31, 2024 -347.75 Mn
Dec 31, 2024 -347.75 Mn
Sep 30, 2024 -29.89 Mn
Sep 30, 2024 -29.89 Mn
Jun 30, 2024 -846,000.00
Jun 30, 2024 -846,000.00
Mar 31, 2024 3.29 Mn
Mar 31, 2024 3.29 Mn
Dec 31, 2023 14.46 Mn
Dec 31, 2023 14.46 Mn